The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9536-9545

  Wang, Chung Huei K ^a   Chan, Leslie W ^a   Johnson, Russell N ^a   Chu, David S H ^a   Shi, Julie ^a   Schellinger, Joan G ^a   Lieber, André ^b   Pun, Suzie H ^a  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Copolymer; Gene therapy; Immune response; Polymerization

Indexed keywords

ADENOVIRUS; CELL BINDING; CELL THERAPY; CELL TYPES; CHEMICAL MANIPULATION; CHO CELL; CLINICAL TRANSLATION; DEGRADABILITY; EX-VIVO; GENE VECTORS; HEPARAN SULFATES; IMMUNE RESPONSE; IMMUNOGENICITY; METHACRYLAMIDES; NEUTRALIZING ANTIBODIES; NON-DIVIDING CELLS; OPTIMAL FORMULATION; PEPTIDE LENGTH; POLYMER MOLECULAR WEIGHT; PROTEOGLYCANS; VIRAL CAPSIDS;

ANTIBODIES; BACTERIOPHAGES; CELLS; COPOLYMERS; ENZYME ACTIVITY; GENE THERAPY; GENE TRANSFER; LIVING POLYMERIZATION; NUCLEIC ACIDS; OPTIMIZATION; POLYMERIZATION; POLYMERS;

PLASTIC COATINGS;

COPOLYMER; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; N (2 HYDROXYPROPYL)METHACRYLAMIDE CO OLIGOLYSINE COPOLYMER; NANOCOATING; NEUTRALIZING ANTIBODY; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL PROTECTION; CHO CELL; FEMALE; GENETIC MANIPULATION; HUMAN; HUMAN CELL; INTERNALIZATION; MOLECULAR WEIGHT; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SYNTHESIS; VIRUS CAPSID;

ACRYLAMIDES; ADENOVIRIDAE; ANIMALS; ANTIBODIES, NEUTRALIZING; CHO CELLS; CRICETINAE; CRICETULUS; CYTOPROTECTION; HELA CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; POLYLYSINE; POLYMERIZATION; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC; VIRUS INTERNALIZATION;

ADENOVIRIDAE; MIRIDAE;

EID: 80053618537     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.069     Document Type: Article

References (62)

1. Benihoud K., Yeh P., Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999, 10(5):440-447.
2. Campos S.K., Barry M.A. Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther 2007, 7(3):189-204.
3. McConnell M.J., Imperiale M.J. Biology of adenovirus and its use as a vector for gene therapy. Hum Gene Ther 2004, 15(11):1022-1033.
4. Howitt J., Anderson C.W., Freimuth P. Adenovirus interaction with its cellular receptor CAR. adenoviruses: model and vectors in virus-host interactions 2003, Springer-Verlag, Berlin, pp. 331-64.
5. Meier O., Greber U.F. Adenovirus endocytosis. J Gene Med 2003, 5(6):451-462.
6. Bergelson J.M., Cunningham J.A., Droguett G., KurtJones E.A., Krithivas A., Hong J.S., et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275(5304):1320-1323.
7. Bewley M.C., Springer K., Zhang Y.B., Freimuth P., Flanagan J.M. Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. Science 1999, 286(5444):1579-1583.
8. Nemerow G.R., Stewart P.L. Role of alpha v integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 1999, 63(3):725-734.
9. Tomko R.P., Xu R.L., Philipson L.H.C.A.R. Mcar: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997, 94(7):3352-3356.
10. Law L.K., Davidson B.L. What does it take to bind CAR?. Mol Ther 2005, 12(4):599-609.
11. Medina-Kauwe L.K. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Deliv Rev 2003, 55(11):1485-1496.
12. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrin-alpha-V-beta-3 and integrin-alpha-V-beta-5 promote adenovirus internalization but not virus attachment. Cell 1993, 73(2):309-319.
13. Kim M., Zinn K.R., Barnett B.G., Sumerel L.A., Krasnykh V., Curiel D.T., et al. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur J Cancer 2002, 38(14):1917-1926.
14. Rebel V.I., Hartnett S., Denham J., Chan M., Finberg R., Sieff C.A. Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells. Stem Cells 2000, 18(3):176-182.
15. Fasbender A., Zabner J., Chillon M., Moninger T.O., Puga A.P., Davidson B.L., et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem 1997, 272(10):6479-6489.
16. Toyoda K., Ooboshi H., Chu Y., Fasbender A., Davidson B.L., Welsh M.J., et al. Cationic polymer and lipids enhance adenovirus-mediated gene transfer to rabbit carotid artery. Stroke 1998, 29(10):2181-2187.
17. Toyoda K., Nakane H., Heistad D.D. Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo. J Cereb Blood Flow Metab 2001, 21(9):1125-1131.
18. Kim P.H., Kim T.I., Yockman J.W., Kim S.W., Yun C.O. The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy. Biomaterials 2010, 31(7):1865-1874.
19. Arcasoy S.M., Latoche J.D., Gondor M., Pitt B.R., Pilewski J.M. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther 1997, 4(1):32-38.
20. Kasman L.M., Barua S., Lu P., Rege K., Voelkel-Johnson C. Polymer-Enhanced adenoviral transduction of CAR-negative bladder cancer cells. Mol Pharm 2009, 6(5):1612-1619.
21. Dodds E., Piper T.A., Murphy S.J., Dickson G. Cationic lipids and polymers are able to enhance adenoviral infection of cultured mouse myotubes. J Neurochem 1999, 72(5):2105-2112.
22. Han J., Zhao D., Zhong Z., Zhang Z., Gong T., Sun X. Combination of adenovirus and cross-linked low molecular weight PEI improves efficiency of gene transduction. Nanotech 2010, 21(10):105-106.
23. Park J.W., Mok H., Park T.G. Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. J Control Rel 2010, 142(2):238-244.
24. Singh R., Tian B.W., Kostarelos K. Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo. Faseb J 2008, 22(9):3389-3402.
25. Zhong Z., Shi S., Han J., Zhang Z., Sun X. Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells. Mol Pharm 2009, 7(1):105-115.
26. Johnson R.N., Burke R.S., Convertine A.J., Hoffman A.S., Stayton P.S., Pun S.H. Synthesis of statistical copolymers containing multiple functional peptides for nucleic acid delivery. Biomacromol 2010, 11(11):3007-3013.
27. McCormick C.L., Lowe A.B. Aqueous RAFT polymerization: recent developments in synthesis of functional water-soluble (Co)polymers with controlled structures. Acc Chem Res 2004, 37(5):312-325.
28. Burke R.S., Pun S.H. Synthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene delivery. Bioconjug Chem 2010, 21(1):140-150.
29. Shayakhmetov D.M., Papayannopoulou T., Stamatoyannopoulos G., Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 2000, 74(6):2567-2583.
30. Shayakhmetov D.M., Li Z.Y., Ternovoi V., Gaggar A., Gharwan H., Lieber A. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol 2003, 77(6):3712-3723.
31. Espenlaub S., Corjon S., Engler T., Fella C., Ogris M., Wagner E., et al. Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications. Hum Gene Ther 2010, 21(9):1155-1167.
32. Murakami P., McCaman M.T. Quantitation of adenovirus DNA and virus particles with the picogreen fluorescent dye. Anal Biochem 1999, 274(2):283-288.
33. Esko J.D., Stewart T.E., Taylor W.H. Animal-cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci U S A 1985, 82(10):3197-3201.
34. Bame K.J., Esko J.D. Undersulfated heparan-sulfate in a chinese-hamster ovary cell mutant defective in heparan-sulfate N-sulfotransferase. J Biol Chem 1989, 264(14):8059-8065.
35. Johnson RN, Chu DSH, Shi J, Schellinger JG, Carlson PM, Pun SH. HPMA-oligolysine copolymers for gene delivery: Optimization of peptide length and polymer molecular weight. J Control Rel., in press, doi:10.1016/j.jconrel.2011.07.009.
36. Shi J, Johnson RN, Schellinger JG, Carlson PM, Pun SH. Reducible HPMA-co-oligolysine copolymers for nucleic acid delivery. Int J Pharm in press.
37. Bidlingmeyer B.A., Cohen S.A., Tarvin T.L. Rapid analysis of amino-acids using pre-columnderivatization. J Chromatogr 1984, 336(1):93-104.
38. Burke R.S., Pun S.H. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem 2008 Mar, 19(3):693-704.
39. Buyens K., Meyer M., Wagner E., Demeester J., De Smedt S.C., Sanders N.N. Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy. J Control Rel 2010 Jan, 141(1):38-41.
40. Fischer D., Li Y.X., Ahlemeyer B., Krieglstein J., Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24(7):1121-1131.
41. Yang J., Chen H., Vlahov I.R., Cheng J.X., Low P.S. Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc Natl Acad Sci 2006 Sep, 103(37):13872-13877.
42. Authier F., Metioui M., Bell A.W., Mort J.S. Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. J Biol Chem 1999, 274(47):33723-33731.
43. Blum J.S., Fiani M.L., Stahl P.D. Proteolytic cleavage of ricin A chain in endosomal vesicles-evidence for the action of endsomal proteases at both neutral and acidic pH. J Biol Chem 1991, 266(33):22091-22095.
44. Chu DSH, Johnson RN, Pun SH. Cathepsin B-sensitive polymers for compartment-specific degradation and nucleic acid release; submitted for publication.
45. Smith J.G., Silvestry M., Lindert S., Lu W.Y., Nemerow G.R., Stewart P.L. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog 2010, 6(6).
46. Wiethoff C.M., Wodrich H., Gerace L., Nemerow G.R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 2005, 79(4):1992-2000.
47. Dechecchi M.C., Melotti P., Bonizzato A., Santacatterina M., Chilosi M., Cabrini G. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 2001, 75(18):8772-8780.
48. Smith T.A.G., Idamakanti N., Rollence M.L., Marshall-Neff J., Kim J., Mulgrew K., et al. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther 2003, 14(8):777-787.
49. Fisher K.D., Stallwood Y., Green N.K., Ulbrich K., Mautner V., Seymour L.W. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther 2001, 8(5):341-348.
50. Green N.K., Herbert C.W., Hale S.J., Hale A.B., Mautner V., Harkins R., et al. Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther 2004, 11(16):1256-1263.
51. Boeckle S., von Gersdorff K., van der Piepen S., Culmsee C., Wagner E., Ogris M. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J Gene Med 2004 Oct, 6(10):1102-1111.
52. Sun W., Davis P.B. Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism. J Control Rel 2010, 146(1):118-127.
53. Leopold P.L., Crystal R.G. Intracellular trafficking of adenovirus: many means to many ends. Adv Drug Deliv Rev 2007, 59(8):810-821.
54. Kaner R.J., Worgall S., Leopold P.L., Stolze E., Milano E., Hidaka C., et al. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor. Am J Respir Cell Mol Biol 1999, 20(3):361-370.
55. Leon R.P., Hedlund T., Meech S.J., Li S.B., Schaack J., Hunger S.P., et al. Adenoviral-mediated gene transfer in lymphocytes. Proc Natl Acad Sci 1998, 95(22):13159-13164.
56. Yoneda A., Asada M., Oda Y., Suzuki M., Imamura T. Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity. Nat Biotech 2000, 18(6):641-644.
57. Mislick K.A., Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci U S A 1996, 93(22):12349-12354.
58. Nwanegbo E., Vardas E., Gao W.T., Whittle H., Sun H.J., Rowe D., et al. Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of the Gambia, South Africa, and the United States. Clin Diagn Lab Immunol 2004, 11(2):351-357.
59. Croyle M.A., Chirmule N., Zhang Y., Wilson J.M. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum Gene Ther 2002, 13(15):1887-1900.
60. Kim P.H., Sohn J.H., Choi J.W., Jung Y., Kim S.W., Haam S., et al. Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin. Biomaterials 2011, 32(9):2314-2326.
61. Subr V., Kostka L., Selby-Milic T., Fisher K., Ulbrich K., Seymour L.W., et al. Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components. J Control Rel 2009, 135(2):152-158.
62. Gorsi B., Stringer S.E. Tinkering with heparan sulfate sulfation to steer development. Trends Cell Biol 2007, 17(4):173-177.